Sarah Cannon Research Institute
Terry Bryant is an experienced finance professional with a strong background in healthcare management. Currently serving as the Assistant Controller at Sarah Cannon Research Institute since February 2020, Terry previously held various leadership roles including Program Director of Finance at Sarah Cannon, CFO at MedManagement, Inc., and Chief Financial Officer at First Call Ambulance Service, Inc. A self-employed former CEO and CFO, Terry has consulted for healthcare entities, offering services in strategic planning and financial projections. With a BS in Business Administration, Accounting from Tennessee Technological University, Terry brings extensive expertise in finance and operations within the healthcare sector.
This person is not in any teams
Sarah Cannon Research Institute
Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. In 2022, SCRI formed a joint venture with former US Oncology Research to enhance clinical trial access and availability across the country. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development. It has conducted nearly 700 first-in-human clinical trials since its inception and contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA today. The combined research network brings together physicians who are actively accruing patients to clinical trials at more than 250 locations in 26 states across the US.